Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2003 March;47(1)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1)

 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):1-2

Foreword

Bombardieri E.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):3-7

On the development of rational standards for nuclear response evaluation

Laking G. R., Price P. M., and EORTC Functional Imaging Group


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):8-13

PET-FDG as predictor of therapy response in patients with colorectal carcinoma

Dimitrakopoulou-Strauss A., Strauss L. G., Rudi J.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):14-21

Prognostic value of FDG-PET in malignant lymphoma

Becherer A., Jaeger U., Szabo M., Kletter K.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):22-30

Gallium scan in adolescents and children with Hodgkin’s disease (HD). Treatment response assessment and prognostic value

Castellani M. R., Cefalo G., Terenziani M., Aliberti G., Maccauro M., Alessi A., Villano C., Bombardieri E.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):31-40

Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy

Boubaker A., Bischof Delaloye A.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):41-5

Assessment of therapy response by FDG PET in pediatric patients

Franzius C., Schober O.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):46-50

MIBI as prognostic factor in breast cancer

Del Vecchio S., Zannetti A., Aloj L., Salvatore M.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):51-7

99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities

Moustafa H., Riad R., Omar W., Zaher A., Ebied E.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):58-62

Tetrofosmin as predictors of tumour response

Fuster D., Viñolas N., Mallafré C., Pavia J., Martín F., Pons F.


 THERAPY RESPONSE IN NUCLEAR MEDICINE
Guest Editor: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2003 March;47(1):63-74

Thallium-201 imaging in the assessment of tumor response to anti-tumor treatments

Berk F., Demir H., Aktolun C


inizio pagina